UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.32B |
| 2 |
Elevance Health
ELV
|
+$282M |
| 3 |
Warner Bros
WBD
|
+$173M |
| 4 |
Visa
V
|
+$167M |
| 5 |
AbbVie
ABBV
|
+$143M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Automatic Data Processing
ADP
|
+$490M |
| 2 |
Amazon
AMZN
|
+$350M |
| 3 |
Microsoft
MSFT
|
+$253M |
| 4 |
Baidu
BIDU
|
+$219M |
| 5 |
TC Energy
TRP
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.54% |
| 2 | Healthcare | 15.22% |
| 3 | Financials | 12.07% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Communication Services | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Warby Parker
WRBY
$3.27B
| $858K | ﹤0.01% |
+76,159
| New | +$1.53M |
|
2052
Harmony Biosciences
HRMY
$2.24B
| $858K | ﹤0.01% |
17,583
| – | – |
|
2053
Cimpress
CMPR
$2.31B
| $856K | ﹤0.01% |
22,009
| – | – |
|
|
CPRX
2054
DELISTED
Catalyst Pharmaceutical
CPRX
| $855K | ﹤0.01% |
121,968
-3,790
| -3% | -$27.8K |
|
2055
Ubiquiti
UI
$34.3B
| $855K | ﹤0.01% |
3,443
| – | – |
|
|
CFB
2056
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $849K | ﹤0.01% |
64,306
+7,596
| +13% | +$102K |
|
2057
Revolution Medicines
RVMD
$44B
| $848K | ﹤0.01% |
43,530
-14,008
| -24% | -$273K |
|
2058
Unisys
UIS
$217M
| $846K | ﹤0.01% |
70,314
+5,895
| +9% | +$83.1K |
|
2059
Axsome Therapeutics
AXSM
$10.9B
| $845K | ﹤0.01% |
22,067
-892
| -4% | -$28.2K |
|
|
PWSC
2060
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $844K | ﹤0.01% |
70,004
+27,286
| +64% | +$375K |
|
2061
WisdomTree
WT
$3.22B
| $843K | ﹤0.01% |
166,314
| – | – |
|
2062
Resources Connection
RGP
$145M
| $841K | ﹤0.01% |
41,265
+4,598
| +13% | +$82.1K |
|
|
CDMO
2063
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $839K | ﹤0.01% |
54,972
-1,647
| -3% | -$24.4K |
|
|
VTLE
2064
DELISTED
Vital Energy
VTLE
| $838K | ﹤0.01% |
12,157
+1,844
| +18% | +$148K |
|
2065
United Fire Group
UFCS
$1.4B
| $837K | ﹤0.01% |
24,466
+2,678
| +12% | +$83.5K |
|
2066
Gogo Inc
GOGO
$492M
| $837K | ﹤0.01% |
51,700
-3,163
| -6% | -$60.2K |
|
|
PTRA
2067
DELISTED
Proterra Inc. Common Stock
PTRA
| $837K | ﹤0.01% |
180,361
+22,000
| +14% | +$135K |
|
2068
Unitil
UTL
$980M
| $834K | ﹤0.01% |
14,204
-1,708
| -11% | -$92.2K |
|
2069
Community Health Systems
CYH
$423M
| $833K | ﹤0.01% |
222,165
+96,316
| +77% | +$678K |
|
2070
Cars.com
CARS
$660M
| $832K | ﹤0.01% |
88,268
+340
| +0.4% | +$3.67K |
|
2071
Origin Bancorp
OBK
$1.66B
| $824K | ﹤0.01% |
21,244
| – | – |
|
2072
Myers Industries
MYE
$1.29B
| $822K | ﹤0.01% |
36,173
+3,459
| +11% | +$78.4K |
|
2073
Xenon Pharmaceuticals
XENE
$6.12B
| $819K | ﹤0.01% |
26,908
-1,928
| -7% | -$58.3K |
|
2074
iShares MSCI Philippines ETF
EPHE
$148M
| $815K | ﹤0.01% |
32,100
| – | – |
|
2075
Marten Transport
MRTN
$1.22B
| $810K | ﹤0.01% |
48,168
| – | – |
|
Similar funds
UBS AM's Q2 2022 Portfolio in Review
As of Q2 2022, UBS AM held 2,854 positions worth $191B, down 18% from $233B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q2 2022 filing shows 130 new, 1,168 increased, 1,130 reduced and 164 closed positions. Its largest new stake was Vanguard Russell 1000 ETF: 543,239 shares worth $93.3M. The largest sale was Automatic Data Processing, an estimated $490M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q2 2022 buy was Vanguard Russell 1000 ETF: 543,239 shares worth $93.3M.
- UBS AM added most to Apple in Q2 2022, an estimated $1.32B increase.
- UBS AM's biggest Q2 2022 reduction was Automatic Data Processing, cutting an estimated $490M.
- UBS AM fully exited TC Energy in Q2 2022, selling an estimated $214M.
- UBS AM's ten largest holdings make up 22% of its $191B portfolio in Q2 2022.
- UBS AM opened 130 new positions and closed 164 in Q2 2022.
- UBS AM's portfolio value fell 18% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q2 2022, filed 12 Aug 2022.